Savara Inc. (SVRA) Financials

SVRA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 192.1 million 48.5 million
March 31, 2026 221.6 million 45.6 million
Dec. 31, 2025 253.4 million 50.3 million
Sept. 30, 2025 140.9 million 46.5 million

SVRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -30.0 million 7.8 million
March 31, 2026 -33.1 million 10.7 million
Dec. 31, 2025 -25.1 million 5.4 million
Sept. 30, 2025 -22.5 million 3.4 million

SVRA Net Income

No data available :(

SVRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 173.0 million 30.1 million -
March 31, 2026 202.8 million 30.1 million 44000
Dec. 31, 2025 235.7 million 29.9 million 7000
Sept. 30, 2025 124.4 million 29.8 million 49000

SVRA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 253.6 million
March 31, 2026 253.3 million
Dec. 31, 2025 222.4 million
Sept. 30, 2025 216.5 million

SVRA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 222000 22.0 million 19.0 million -
March 31, 2026 54000 23.4 million 15.5 million -
Dec. 31, 2025 2000 20.9 million 12.5 million -
Sept. 30, 2025 2000 20.6 million 9.6 million -

SVRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 66000
Dec. 31, 2025 - 40000
Sept. 30, 2025 - 20.6 million

SVRA

Price: $5.38

52 week price:
2.43
7.01

Earnings Per Share: -0.54 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 765007

Ebitda: -6.6 million

Market Capitalization: 1.1 billion

Links: